Bottom line
FPHAX vs IHE: the short answer
FPHAX (Pharmaceuticals Portfolio) and IHE (iShares U.S. Pharmaceuticals ETF) share a meaningful slice of their top holdings — about 40% by weight.
IHE is cheaper at 0.37% vs 0.67% — a difference of $30 a year per $10,000 invested.
Over five years, FPHAX returned +12.6% a year vs +9.1% for IHE (reporting dates differ).
Updated Nov 19, 2026
FPHAX vs IHE side by side
| FPHAX | IHE | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.67% | 0.37% |
| Annual cost per $10k | $67 | $37 |
| 10-yr cost on $10k (prospectus) | $835 | $468 |
| Max front load | — | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +30.3% | +31.7% |
| 5-yr return (annualized) | +12.6% | +9.1% |
| 10-yr return (annualized) | +10.0% | +6.2% |
| Best quarter | +18.5% | +17.6% |
| Worst quarter | −13.6% | −16.0% |
| Net assets (fund) | $1.5B | $1.1B |
| Number of holdings | 57 | 59 |
| Portfolio turnover | 77% | 29% |
| Returns as of | Apr 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FPHAX | IHE | Difference |
|---|---|---|---|
| 2025 | +30.3% | +31.7% | −1.5% |
| 2024 | +9.4% | +8.1% | +1.3% |
| 2023 | +12.5% | +1.0% | +11.5% |
| 2022 | +1.0% | −4.8% | +5.8% |
| 2021 | +11.8% | +12.8% | −1.0% |
| 2020 | +11.1% | +13.8% | −2.7% |
| 2019 | +31.6% | +15.5% | +16.1% |
| 2018 | +5.8% | −7.7% | +13.5% |
| 2017 | +10.7% | +10.7% | +0.0% |
| 2016 | −16.3% | −11.7% | −4.6% |
Source: Fund prospectus bar charts
Holdings overlap
6 of FPHAX's top 25 holdings also appear in IHE's top 25.
| Holding | FPHAX | IHE |
|---|---|---|
| ELI LILLY and CO | 28.78% | 22.25% |
| Viatris Inc | 5.45% | 4.22% |
| MERCK and CO INC | 4.74% | 4.55% |
| Elanco Animal Health Inc | 4.15% | 2.81% |
| JOHNSON and JOHNSON | 3.77% | 22.44% |
| Axsome Therapeutics Inc | 1.08% | 2.42% |
Source: SEC Form N-PORT
FPHAX top 10
- ELI LILLY and CO — 28.78%
- Gsk Plc — 8.17%
- Viatris Inc — 5.45%
- Ucb Sa — 5.09%
- MERCK and CO INC — 4.74%
- Roche Holding Ag — 4.54%
- Legend Biotech Corp — 4.53%
- Astrazeneca Plc — 4.22%
- Elanco Animal Health Inc — 4.15%
- Jazz Pharmaceuticals Plc — 4.09%
IHE top 10
- Johnson & Johnson — 22.44%
- Eli Lilly And Company — 22.25%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
- Merck & Co., Inc. — 4.55%
- Bristol-myers Squibb Company — 4.37%
- Royalty Pharma Plc — 4.34%
- Viatris Inc. — 4.22%
- Pfizer Inc. — 3.96%
- Zoetis Inc. — 3.73%
- Jazz Pharmaceuticals Public Limited Company — 3.45%
FAQ
What is the difference between FPHAX and IHE?
Which is cheaper, FPHAX or IHE?
Should I own both FPHAX and IHE?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.